Two senior officials serving the Food and Drug Administration’s vaccine review arm are reportedly set to leave the agency over the next few months.

Both Marion Gruber, director of the FDA’s Office of Vaccines Research and Review, and deputy director Phil Krause will depart this fall — Gruber in October and Krause in November, according to CNBC.

Recommended Stories

Experts dubious of fourth COVID-19 booster doses as Israeli hospital launches tests

No COVID-19 booster shot needed ‘at this time,’ FDA and CDC say

Vaccine experts question fourth shot as companies seek expanded authorization